High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients.

Giansanti, Manuela; Karimi, Terry; Faraoni, Isabella; Graziani, Grazia

Giansanti, Manuela; Karimi, Terry; Faraoni, Isabella; Graziani, Grazia.

Afiliação

Giansanti M; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
Karimi T; Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, 00185 Rome, Italy.
Faraoni I; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
Graziani G; Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.

Cancers (Basel) ; 13(6)2021 Mar 20.

Article em En | MEDLINE | ID: mdl-33804775

Palavras-chave

5-hydroxymethylcytosine; DNA damage; IDH1/2; PARP inhibitors; ROS; TET2; WT1; ascorbate; hypomethylating agents; vitamin C

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália